A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain
Phase 4
Withdrawn
- Conditions
- Postoperative PainHallux Valgus
- Interventions
- Registration Number
- NCT01190722
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).
- Detailed Description
The aim of the present study is to compare patients' satisfaction with pain medication during the first 7 first postoperative days following elective hallux valgus surgery in general anaesthesia between etoricoxib and diclofenac in a prospective randomised double-blind study design.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- American Society of Anesthesiology (ASA) physiological class 1-2 patients
- aged 18-65 years
- scheduled for elective hallux valgus surgery in general anesthesia
Exclusion Criteria
- NSAID allergy
- liver disease
- renal disease
- uncontrolled cardiovascular disease
- Lithium therapy
- chronic pain
- regular analgesia use
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description etoricoxib etoricoxib active study drug, coxib diclofenac Diclofenac active traditional NSAID control
- Primary Outcome Measures
Name Time Method Patients Global Evaluation of Study Medication postoperative day 1-6 Patients self-assessment of global satisfaction with pain medication
- Secondary Outcome Measures
Name Time Method